RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Cell-type specific gene signatures reveal novel immune checkpoints and prognostic markers in lung cancer.
Cell-type specific gene signatures reveal novel immune checkpoints and prognostic markers in lung cancer.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
肿瘤微环境(TME)是免疫细胞、基质细胞和恶性细胞之间复杂的相互作用网络,其交互作用塑造了癌症进展和治疗反应。在本研究中,我们进行了整合性单细胞转录组分析,以定义细胞类型特异性基因特征,重点关注免疫-肿瘤通讯、耗竭状态及其预后意义。
我们推导了B细胞、CD8⁺ T细胞、成纤维细胞、巨噬细胞、NK细胞、T细胞、Tregs、肿瘤细胞和未分类簇的30基因特征。配体-受体映射揭示了广泛的通讯,包括巨噬细胞-成纤维细胞和Treg-肿瘤轴。拟时序分析进一步显示免疫耗竭是一个动态过程,富集了检查点基因如PDCD1、CTLA4、LAG3和TIGIT,尤其是在Tregs和耗竭CD8⁺ T细胞中。代表性基因的生存分析揭示了免疫和基质活性的相反效应:MS4A1(B细胞特征)和TPPP3(肿瘤特征)与改善的预后相关,而成纤维细胞特异性COL1A1预测不良结局。纳入特征较少的基因突出了新的预后信号。特征之间的相关网络强调了免疫和基质区室的功能相互依赖性。
总之,本研究提供了一个系统层面的框架,将转录与生存结局联系起来。通过结合已建立的免疫检查点和新的候选基因,我们的发现扩展了肺癌预后分层和治疗靶向的生物标志物图谱。
The tumor microenvironment (TME) is a complex interplay of immune, stromal, and malignant cells whose interactions shape cancer progression and therapeutic responses. In this study, we performed an integrative single-cell transcriptomic analysis to define cell-type-specific gene signatures with emphasis on immune-tumor communication, exhaustion states, and their prognostic implications.
We derived 30-gene signatures for B cells, CD8⁺ T cells, fibroblasts, macrophages, NK cells, T cells, Tregs, tumor cells, and unclassified clusters. Ligand-receptor mapping revealed widespread communication, including macrophage-fibroblast and Treg-tumor axes. Pseudotime analysis further showed immune exhaustion as a dynamic process enriched with checkpoint genes such as PDCD1, CTLA4, LAG3, and TIGIT, particularly within Tregs and exhausted CD8⁺ T cells.
Survival analysis of representative genes revealed contrasting effects of immune and stromal activity: MS4A1 (B-cell signature) and TPPP3 (tumor signature) correlated with improved prognosis, whereas fibroblast-specific COL1A1 predicted poor outcomes. Incorporation of less-characterized genes highlighted novel prognostic signals. Correlation networks among signatures underscored the functional interdependence of immune and stromal compartments.
Together, this study provides a systems-level framework linking transcriptional with survival outcomes. By combining established immune checkpoints with novel candidates, our findings expand the biomarker landscape for prognostic stratification and therapeutic targeting in lung cancer.
MEMBER ACCOUNT
登录成功会直接打开下一页。